The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
Open accessAbstract
Purpose: Merkel cell carcinoma (MCC) is a polyomavirus-associated skin cancer that is frequently lethal and lacks established prognostic biomarkers. This study sought to identify biomarkers that improve prognostic accuracy and provide insight into MCC biology. Patients and Methods: Gene expression profiles of 35 MCC tumors were clustered based on prognosis. The cluster of genes overexpressed in good-prognosis tumors was tested for biologic process enrichment. Relevant mRNA expression differences were confirmed by quantitative polymerase chain reaction and immunohistochemistry. An independent set of 146 nonoverlapping MCC tumors (median follow-up, 25 months among 116 living patients) was employed for biomarker validation. Univariate and multivariate Cox regression analyses were performed. Results: Immune response gene signatures were prominent in patients with good prognoses. In particular, genes associated with cytotoxic CD8+ lymphocytes were overexpressed in tumors from patients with favorable prognoses. In the independent validation set, cases with robust intratumoral CD8+ lymphocyte infiltration had improved outcomes (100% MCC-specific survival, n = 26) compared with instances characterized by sparse infiltration (60% survival, n = 120). Only stage and intratumoral CD8 infiltration (but not age, sex, or CD8+ lymphocytes localized to the tumor-stroma interface) were significant in both univariate and multivariate Cox regression analyses. Notably, traditional histologic identification of tumor-infiltrating lymphocytes was not a significant independent predictor of survival. Conclusion: Intratumoral CD8+ lymphocyte infiltration can be readily assessed on paraffin-embedded tissue, is independently associated with improved MCC-specific survival, and therefore, may provide prognostic information that enhances established MCC staging protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397 · cited 1×
“This is also true for other cancers, such as ovarian cancer and colon cancer.(27,34) Second, immunohistochemical CD8 evaluation may be more sensitive and specific for identification of TILs than routine histology.”
BackgroundClonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
Feng, H., Shuda, M., Chang, Y., & Moore, P. S. (2008) · Science · doi:10.1126/science.1152586 · Cited by 3,208
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S.-J., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,636
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
Harlin, H., Meng, Y., Peterson, A. C., Zha, Y., Tretiakova, M., Slingluff, C., McKee, M., & Gajewski, T. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2281 · Cited by 1,121
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features
Heath, M., Jaimes, N., Lemos, B., Mostaghimi, A., Wang, L. C., Peñas, P. F., & Nghiem, P. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.11.020 · Cited by 934
Self-citationThomas, P. D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg115 · Cited by 665
Lemos, B. D., Storer, B. E., Iyer, J. G., Phillips, J. L., Bichakjian, C. K., Fang, L. C., Johnson, T. M., Liegeois-Kwon, N. J., Otley, C. C., Paulson, K. G., et al. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.02.056 · Cited by 559
Self-citationMerkel cell carcinoma and HIV infection
Engels, E. A., Frisch, M., Goedert, J. J., Biggar, R. J., & Miller, R. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07668-7 · Cited by 550
Albores‐Saavedra, J., Batich, K., Chable‐Montero, F., Sagy, N., Schwartz, A. M., & Henson, D. E. (2010) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2009.01370.x · Cited by 546
Thomas, P. D., Kejariwal, A., Guo, N., Mi, H., Campbell, M. J., Muruganujan, A., & Lazareva-Ulitsky, B. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl229 · Cited by 499
A novel receptor involved in T-cell activation
Cocks, B. G., Chang, C.-C. J., Carballido, J. M., Yssel, H., de Vries, J. E., & Aversa, G. (1995) · Nature · doi:10.1038/376260a0 · Cited by 479
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens
Houben, R., Shuda, M., Weinkam, R., Schrama, D., Feng, H., Chang, Y., Moore, P. S., & Becker, J. C. (2010) · Journal of Virology · doi:10.1128/jvi.02400-09 · Cited by 457
Self-citationShuda, M., Arora, R., Kwun, H. J., Feng, H., Sarid, R., Fernández‐Figueras, M., Tolstov, Y., Gjoerup, O., Mansukhani, M. M., Swerdlow, S. H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24510 · Cited by 373
MC Polyomavirus Is Frequently Present in Merkel Cell Carcinoma of European Patients
Becker, J. C., Houben, R., Ugurel, S., Trefzer, U., Pföhler, C., & Schrama, D. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.198 · Cited by 372
Self-citationKassem, A., Schöpflin, A., Diaz, C., Weyers, W., Stickeler, E., Werner, M., & zur Hausen, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0949 · Cited by 369
Paulson, K. G., Warcola, A. H., Feng, Q., Kiviat, N. B., Leonard, J. H., & Nghiem, P. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.229 · Cited by 335
Self-citationBUSAM, K. J., Jungbluth, A. A., Rekthman, N., Coit, D. C., Pulitzer, M. P., Bini, J., Arora, R., Hanson, N. C., Tassello, J., Frosina, D., et al. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181aa30a5 · Cited by 272
Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
Carter, J. J., Paulson, K. G., Wipf, G. C., Miranda, D., Madeleine, M. M., Johnson, L. G., Lemos, B. D., Lee, S., Warcola, A. H., Iyer, J. G., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp332 · Cited by 238
Self-citationMerkel cell carcinoma: Histologic features and prognosis
Andea, A. A., Coit, D. G., Amin, B., & Busam, K. J. (2008) · Cancer · doi:10.1002/cncr.23874 · Cited by 215
Merkel Cell Carcinoma: More Deaths but Still No Pathway to Blame
Lemos, B., & Nghiem, P. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700925 · Cited by 213
Self-citationBhatia, K. G., Goedert, J. J., Modali, R., Preiss, L., & Ayers, L. W. (2009) · International Journal of Cancer · doi:10.1002/ijc.24676 · Cited by 152
Koljonen, V., Kukko, H., Pukkala, E., Sankila, R. J., Böhling, T., Tukiainen, E. J., Sihto, H. J., & Joensuu, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605306 · Cited by 144
Detection of Merkel cell polyomavirus in Merkel cell carcinoma and Kaposi's sarcoma
Katano, H., 伊東, 秀., Suzuki, Y., Nakamura, T., Sato, Y., Tsuji, T., Matsuo, K., Nakagawa, H., & Sata, T. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21608 · Cited by 109
Hussain, S. K., Sundquist, J., & Hemminki, K. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.426 · Cited by 104
CCL5 as an adjuvant for cancer immunotherapy
Lapteva, N., & Huang, X. F. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712591003657128 · Cited by 92
CD56: a useful marker for diagnosing Merkel cell carcinoma
Kurokawa, M., Nabeshima, K., Akiyama, Y., Maeda, S.-I., Nishida, T., Nakayama, F., Amano, M., OGATA, K., & Setoyama, M. (2003) · Journal of Dermatological Science · doi:10.1016/s0923-1811(03)00029-x · Cited by 80
Cited by
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
PD-1 Blockade with pembrolizumab in advanced Merkel-cell carcinoma
Nghiem, P. T., Bhatia, S., Lipson, E. J., Kudchadkar, R. R., Miller, N. J., Annamalai, L., Berry, S., Chartash, E. K., Daud, A., Fling, S. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603702 · Cited by 1,258
Self-citationThe secret ally: immunostimulation by anticancer drugs
Galluzzi, L., Senovilla, L., Zitvogel, L., & Kroemer, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3626 · Cited by 670
Becker, J. C., Stang, A., DeCaprio, J. A., Cerroni, L., Lebbé, C., Veness, M., & Nghiem, P. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.77 · Cited by 645
Self-citation
Metadata
- Authors
- Paulson, K. G., Iyer, J. G., Tegeder, A. R., Thibodeau, R., Schelter, J., Koba, S., Schrama, D., Simonson, W. T., Lemos, B. D., Byrd, D. R., Koelle, D. M., Galloway, D. A., Leonard, J. H., Madeleine, M. M., Argenyi, Z. B., Disis, M. L., Becker, J. C., Cleary, M. A., & Nghiem, P.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-04-20
- Volume
- 29
- Issue
- 12
- Pages
- 1539-1546
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2139541665
- Cited by
- 302
- References
- 30
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.